2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

¡®ÇÏÆ®Æä¾î¸µ¡¯ Æä¾î¸µºÏ, 33°¡Áö Áú¹®ÀÇ ´äÀÌ Ã¥ÀÌ µÆ´Ù

½Ì±ÛÀÎ ÀÌû¾Æ, Ãֽÿø, ¹Ì¹Ì ´äº¯ÀÌ ±Ã±ÝÇÒ Á¤µµ·Î °¡Ä¡ Àִ å
ä³ÎA »õ ¿¬¾Ö ¿¹´É ‘ÇÏÆ®Æä¾î¸µ’ÀÌ Ã¹ ÃÔ¿µºÎÅÍ ‘°ú¸ôÀÔ’¿¡ ºüÁø 5MC À±Á¾½Å-ÀÌû¾Æ-Ãֽÿø-¹Ì¹Ì-¹ÚÁö¼± ±³¼öÀÇ ½ºÆ©µð¿À ÃÔ¿µ ½ºÆ¿À» °ø°³Çß´Ù. 3¿ù 7ÀÏ(±Ý) ¹ã 10½Ã 50ºÐ ù ¹æ¼ÛÇϴ ä³ÎA ‘ÇÏÆ®Æä¾î¸µ’Àº °áÈ¥ÇÏ°í ½ÍÀº ûÃáµéÀÇ ³¶¸¸°ú ÇöŸ Ãæ¸¸ÇÑ È¥Àü ¿¬¾Ö Àϱ⸦ ±×·Á³»´Â ¿¬¾Ö ÇÁ·Î±×·¥ÀÌ´Ù. ÀÌÁ¦´Â °áÈ¥ÇÒ »ç¶÷°ú ¿¬¾ÖÇÏ°í ½ÍÀº ûÃá³²³àµéÀÌ ´Ü¼øÇÑ ‘½æ’À» ³Ñ¾î, °áÈ¥ »ó´ë¸¦ ã±â À§ÇØ ÁøÁöÇÏ°Ô ¼­·Î¸¦ ¾Ë¾Æ°¡´Â °úÁ¤À» ´ã¾Æ³½´Ù. Ã⿬ÁøµéÀº Áö³­ÇØ ¸» ¾Æ¸§´Ù¿î ³¶¸¸ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
DGB´ë±¸ÀºÇà, ÀºÇà±Ç ÃÖÃÊ ¡®¿ÜÈ­ ÀçȯÀü¡¯ ¼ö¼ö·á Àü¸é ¹«·á (2024-04-17)
The LYCRA Company Presents Seminars on Sustainable Elastane ... (2024-09-14)
ºûÀÇ ½Ã¾îÅÍ-ºûÀÇ º¡Ä¿, Ãß¼® ¸ÂÀÌ Ç³¼ºÇÑ ÇÁ·Î±×·¥ (2023-09-28)
¿ÀÇǽº ºôµù Æò±Õ °ø½Ç·ü 0.4pp »ó½Â... 2.6% (2024-02-25)
±¹³» ÃÖÃÊ Å©·çÁî ¹ÂÁ÷Æä½ºÆ¼¹ú ¡®ÀÕÃ÷´õ½±ÄÚ¸®¾Æ 2024¡¯ (2024-04-14)
PUMA Appoints Markus Neubrand as Chief Financial Officer (2024-10-07)
Ǫ¸¶ 'º§·Î½ÃƼ ³ªÀÌÆ®·Î 2 GTX¡¯ Ãâ½Ã (2022-10-05)
GS25, »õÇØ ù³¯ºÎÅÍ °«¼¼ÀÏ Çà»ç µ¹ÀÔ (2024-01-01)
BeiGene Enters Next Phase of Global Growth with Announcement... (2024-08-16)
Sunn Stream Chooses Brightcove to Operate New Streaming Serv... (2024-07-21)
º£Æ®³² GS25 300È£Á¡ µ¹ÆÄ (2024-05-30)
DGB´ë±¸ÀºÇà ¡®´ë±¸ ÆíÀÔ ±ºÀ§±º¡¯ À̵¿Á¡Æ÷ ±ÝÀ¶ ¼­ºñ½º (2023-07-29)
¹è¿ì ÃÖÁ¤ÀÎ, MBC ¡®¿ì¸®, Áý¡¯ ij½ºÆÃ... ±èÈñ¼±°ú È£Èí ¸ÂÃá´Ù (2024-04-08)
µÈ´Ù µÈ´Ù Ã¥¾²±â°¡ µÈ´Ù (2016-01-07)
KOTRA ¡®º£Æ®³²¡¤Àδϡ¤Àεµ 3°³±¹ °ø±Þ¸Á ÀçÆí ´ëÀÀ ¼¼¹Ì³ª¡¯ (2023-11-30)
PUMA RE:SUEDE Pilot Project Turns Experimental Sneakers Into... (2023-11-30)
û¼Ò³â ÀÎÅÏ ±Û·Î¹ú ÆÄÆ®³Ê½Ê È®´ë (2023-12-23)
Ãë¾÷Áغñ»ý ¾îÇÐÆò±Õ ÅäÀÍ 682Á¡, Å佺 ·¹º§5 (2016-01-26)
LG»ýȰ°Ç°­, ´õÆäÀ̽º¼¥ »õ ¸ðµ¨¿¡ ¼¼ºìƾ ¿ø¿ì ¹ßŹ (2024-04-28)
¡®³ª´Â SOLO' ¼Ö·Î¹Î¹Ú 4ź ¿Á¼øÁî&¦ ƯÁý (2024-03-07)
½º¸¶Æ®Æù °úÀÇÁ¸ û¼Ò³â 40.1%... ¼ôÆû ¼¼´ë º´µé¾î °£´Ù (2023-12-20)
¹è¿ì ±è¿µ¿õ, µå¶ó¸¶ ¡®²ÀµÎÀÇ °èÀý¡¯ Áß½Ä æµ ÇÕ·ù (2023-01-13)
´Ù¿ì±â¼ú »Ñ¸®¿À, ±¹³» ÃÖÃÊ ¡®AI ¹®ÀÚ¼­ºñ½º¡¯ Ãâ½Ã (2023-12-17)
°£ÆíÇÏ°Ô ¹ß¶ó¸Ô´Â ¡®µ¿¿øÂüÄ¡ ½ºÇÁ·¹µå&Æ©³ªÆä¡¯ (2024-04-25)
Ÿ°ø ÇÊ¿ä ¾ø´Â Ãʰ£Æí ¿¡¹Ù Ŭ¸®³Ê '´ÚÅÍ¿¡¹Ù' Ãâ½Ã (2017-05-24)
       [ÀÌÀü][1]....[788][789][790][791][792][793][794][795][796]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..